CCM Duopharma Biotech gets RM10 million credit facilities from OCBC

PETALING JAYA: CCM Duopharma Biotech Bhd has received an additional RM10 million credit facilities from OCBC Bank (Malaysia) Bhd.
The group said in a filing with the stock exchange that its wholly owned subsidiary Duopharma (M) Sdn Bhd had entered and executed a credit facilities agreement with OCBC.
It has been maintaining a RM9.55 million credit facilities from OCBC since 2009 and the limit has been fully utilised as at March 31, 2017.
In view of that, OCBC had offered an additional limit of RM10 million to the existing credit facilities to cater for any upcoming and future business requirement.
"With the additional RM10 million credit facilities, the new total limit from OCBC will be RM19.55 million," CCM Duopharma said.
Shares of CCM Duopharma were untraded in the morning session today.